Page last updated: 2024-11-08

yersiniabactin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

yersiniabactin: from clinical isolates of Yersinia enterocolitica; an iron-chelating virulence factor of Yersinia pestis; yersiniabactin is a thiazole phenol analog of pyochelin; biosynthesized from salicylate, cysteine and malonyl CoA [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

yersiniabactin : A member of the class of thiazolidines that is (4S)-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid which is substituted at position 2 by a (1S)-1-hydroxy-1-{(4R)-2-[(4R)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl group. A siderophore found in the gram-negative bacterium species, Yersinia enterocolitica and Yersinia pestis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID443589
CHEMBL ID1221692
CHEBI ID29707
MeSH IDM0272710

Synonyms (12)

Synonym
CHEMBL1221692 ,
chebi:29707 ,
C12038 ,
yersiniabactin
AC1NUWEN ,
(4s)-2-[(1s)-1-hydroxy-1-{(4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl]-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid
(4s)-2-[(2s)-2-hydroxy-1,1-dimethyl-2-[(4r)-2-[(2e,4r)-2-(6-oxocyclohexa-2,4-dien-1-ylidene)thiazolidin-4-yl]thiazolidin-4-yl]ethyl]-4-methyl-5h-thiazole-4-carboxylic acid
152166-40-0
(4s)-2-((1s)-1-hydroxy-1-((4r)-2-((r)-2-(2-hydroxyphenyl)-4,5-dihydrothiazol-4-yl)thiazolidin-4-yl)-2-methylpropan-2-yl)-4-methyl-4,5-dihydrothiazole-4-carboxylic acid
(4s)-2-[(1s)-1-hydroxy-1-[(4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl]-2-methylpropan-2-yl]-4-methyl-5h-1,3-thiazole-4-carboxylic acid
Q8052674
DTXSID501029725

Research Excerpts

Overview

Yersiniabactin (Ybt) is a hybrid polyketide-nonribosomal complex natural product also known as a siderophore for its iron chelation properties. It is natively produced by the pathogen Yersinia pestis.

ExcerptReferenceRelevance
"Yersiniabactin (Ybt) is a hybrid polyketide-nonribosomal complex natural product also known as a siderophore for its iron chelation properties. "( Consolidated plasmid Design for Stabilized Heterologous Production of the complex natural product Siderophore Yersiniabactin.
Bruno, M; Pfeifer, BA; Qi, R; Swayambhu, G; Zhang, G, 2021
)
2.28
"Yersiniabactin (Ybt) is a mixed nonribosomal peptide-polyketide natural product that binds a wide range of metals with the potential to impact processes requiring metal retrieval and removal. "( Increased production of yersiniabactin and an anthranilate analog through media optimization.
Ahmadi, MK; Moscatello, N; Pfeifer, BA; Qi, R, 2017
)
2.2
"Yersiniabactin (Ybt) is a metal-binding natural product that has been re-purposed for water treatment. "( Yersiniabactin metal binding characterization and removal of nickel from industrial wastewater.
Moscatello, NJ; Pfeifer, BA, 2017
)
3.34
"Yersiniabactin (Ybt) is a mixed nonribosomal peptide-polyketide natural product natively produced by the pathogen Yersinia pestis. "( Total Biosynthesis and Diverse Applications of the Nonribosomal Peptide-Polyketide Siderophore Yersiniabactin.
Ahmadi, MK; Fawaz, S; Jones, CH; Pfeifer, BA; Zhang, G, 2015
)
2.08
"Yersiniabactin (Ybt) is a siderophore-dependent iron uptake system encoded on a pathogenicity island that is widespread among pathogenic bacteria including the Yersiniae. "( Yersiniabactin iron uptake: mechanisms and role in Yersinia pestis pathogenesis.
Fetherston, JD; Perry, RD, 2011
)
3.25
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
siderophoreAny of low-molecular-mass iron(III)-chelating compounds produced by microorganisms for the purpose of the transport and sequestration of iron.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
thiazolidines
monocarboxylic acidAn oxoacid containing a single carboxy group.
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID503845Inhibition of siderophore production in Yersinia pestis at 200 uM after 12 hrs by radiometric assay relative to control2005Nature chemical biology, Jun, Volume: 1, Issue:1
Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (118)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (6.78)18.2507
2000's49 (41.53)29.6817
2010's46 (38.98)24.3611
2020's15 (12.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.54 (24.57)
Research Supply Index4.78 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (5.93%)6.00%
Case Studies1 (0.85%)4.05%
Observational0 (0.00%)0.25%
Other110 (93.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]